HomeSTOK • NASDAQ
add
Stoke Therapeutics Inc
Previous close
$30.87
Day range
$30.90 - $31.78
Year range
$5.35 - $38.69
Market cap
1.81B USD
Avg Volume
1.03M
P/E ratio
23.94
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 10.63M | 117.25% |
Operating expense | 53.72M | 53.95% |
Net income | -38.35M | -45.09% |
Net profit margin | -360.68 | 33.21% |
Earnings per share | -0.65 | -38.30% |
EBITDA | -42.65M | -44.75% |
Effective tax rate | 3.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 248.31M | 3.81% |
Total assets | 360.26M | 22.82% |
Total liabilities | 52.16M | -14.78% |
Total equity | 308.10M | — |
Shares outstanding | 57.12M | — |
Price to book | 5.52 | — |
Return on assets | -28.93% | — |
Return on capital | -33.08% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -38.35M | -45.09% |
Cash from operations | -30.37M | -40.49% |
Cash from investing | 9.09M | 130.31% |
Cash from financing | 3.12M | -61.76% |
Net change in cash | -18.15M | 58.23% |
Free cash flow | -17.91M | -275.26% |
About
Founded
2014
Headquarters
Website
Employees
128
